Sphingomyelin-ceramide turnover in CD28 costimulatory signaling
- 1 July 1995
- journal article
- Published by Wiley in European Journal of Immunology
- Vol. 25 (7), 1999-2004
- https://doi.org/10.1002/eji.1830250730
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.The Journal of Experimental Medicine, 1994
- B70 antigen is a second ligand for CTLA-4 and CD28Nature, 1993
- The Role of the CD28 Receptor During T Cell Responses to AntigenAnnual Review of Immunology, 1993
- CTLA-4 is a second receptor for the B cell activation antigen B7.The Journal of Experimental Medicine, 1991
- Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.The Journal of Experimental Medicine, 1991
- T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.Proceedings of the National Academy of Sciences, 1990
- Role of the CD28 receptor in T-cell activationImmunology Today, 1990
- Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signalling Pathway Determines the Outcome of T Cell Antigen Receptor OccupancyAnnual Review of Immunology, 1989
- A Differential Molecular Biology Search for Genes Preferentially Expressed in Functional T Lymphocytes: The CTLA GenesImmunological Reviews, 1988
- A new member of the immunoglobulin superfamily—CTLA-4Nature, 1987